Part 1: Use of QCI Interpret to elucidate precision in breast cancer targeted therapy
Breast cancer is a complex heterogeneous disease, with each subtype characterised by distinct clinical features and molecular alterations. The heterogeneity of breast cancer has presented massive challenges for identifying appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond stratification of patients by hormone receptor and epidermal growth factor receptor status. QIAGEN Clinical Insight Interpret is a web-based application for the annotation, classification, and reporting of actionable variants from NGS data in clinical genomics laboratories.